INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -5.6% | 10,070 | -5.7% | 0.00% | – |
| Q2 2022 | $18,000 | -58.1% | 10,684 | -11.4% | 0.00% | – |
| Q1 2022 | $43,000 | -24.6% | 12,052 | +6.3% | 0.00% | – |
| Q4 2021 | $57,000 | -57.1% | 11,340 | -38.8% | 0.00% | – |
| Q3 2021 | $133,000 | -22.7% | 18,521 | -0.4% | 0.00% | – |
| Q2 2021 | $172,000 | -10.9% | 18,595 | -10.6% | 0.00% | – |
| Q1 2021 | $193,000 | -15.7% | 20,790 | -19.7% | 0.00% | -100.0% |
| Q4 2020 | $229,000 | -65.1% | 25,880 | -54.3% | 0.00% | -50.0% |
| Q3 2020 | $656,000 | -34.9% | 56,589 | +51.4% | 0.00% | -33.3% |
| Q2 2020 | $1,008,000 | +380.0% | 37,389 | +32.6% | 0.00% | +200.0% |
| Q1 2020 | $210,000 | – | 28,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |